FBLTX
Price
$6.26
Change
-$0.05 (-0.79%)
Updated
Sep 18 closing price
Net Assets
12.81B
VEDTX
Price
$17.94
Change
-$0.17 (-0.94%)
Updated
Sep 18 closing price
Net Assets
4.13B
Interact to see
Advertisement

FBLTX vs VEDTX

FBLTX vs VEDTX Comparison Chart in %
View a ticker or compare two or three
VS
FBLTX vs. VEDTX commentary
Sep 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBLTX is a Hold and VEDTX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FBLTX has more cash in the bank: 12.8B vs. VEDTX (4.14B). VEDTX pays higher dividends than FBLTX: VEDTX (5.41) vs FBLTX (4.39). FBLTX was incepted earlier than VEDTX: FBLTX (11 years) vs VEDTX (19 years). FBLTX (0.05) and VEDTX (0.05) have similar cost to investors . FBLTX is a more actively managed with annual turnover of: 25.00 vs. VEDTX (15.00). FBLTX has a lower initial minimum investment than VEDTX: FBLTX (0) vs VEDTX (5000000). FBLTX annual gain was more profitable for investors over the last year : -4.73 vs. VEDTX (-7.96). FBLTX return over 5 years is better than : -35.18 vs. VEDTX (-49.26).
FBLTXVEDTXFBLTX / VEDTX
Total Expense Ratio0.030.0560%
Annual Report Gross Expense Ratio0.050.05100%
Fund Existence11 years19 years-
Gain YTD-4.315-6.26469%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets12.8B4.14B310%
Annual Yield % from dividends4.395.4181%
Returns for 1 year-4.73-7.9659%
Returns for 3 years-0.56-8.796%
Returns for 5 years-35.18-49.2671%
Returns for 10 years-23.58-38.4361%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FLCKX44.210.53
+1.21%
Fidelity Leveraged Company Stock K
TBCIX215.211.28
+0.60%
T. Rowe Price Blue Chip Growth I
GRGTX55.15-0.14
-0.25%
Goldman Sachs Equity Income Inv
FIJCX91.57-0.62
-0.67%
Fidelity Advisor Consumer Staples Z
RYOIX93.54-1.10
-1.16%
Rydex Biotechnology Inv